R. Mamelok

发表

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.

M. Pescovitz, T. van Gelder, R. V. van Hest, 2006, Journal of the American Society of Nephrology : JASN.

Daclizumab to prevent rejection after cardiac transplantation.

R. Starling, R. Hershberger, R. Kormos, 2005, The New England journal of medicine.

Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.

D. Renlund, H. Valantine, D. Mancini, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation

L. Shaw, B. Meiser, B. Toenshoff, 2006, Therapeutic drug monitoring.

From Mechanisms to Long-Term Benefits

R. Mamelok, 2005, Transplantation.

Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant.

T. Gooley, R. Bowden, J. V. van Burik, 1996, The Journal of infectious diseases.

How Delayed Graft Function Impacts Exposure to Mycophenolic Acid in Patients After Renal Transplantation

V. Armstrong, K. Budde, T. van Gelder, 2011, Therapeutic drug monitoring.

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

J. D. de Fijter, A. Hartmann, K. Budde, 2008, Pharmacogenetics and genomics.

Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS‐1 and ATMOS‐2 phase 3 randomized controlled trials

J. Drew, A. Nast, D. Pariser, 2019, Journal of the American Academy of Dermatology.

Comparison of Mycophenolate Mofetil and Azathioprine for Prevention of Bronchiolitis Obliterans Syndrome in De Novo Lung Transplant Recipients

R. Speich, P. Corris, C. Knoop, 2006, Transplantation.

Effects of trypsin and protein modification on the renal transporter ofp-aminohippurate

R. Mamelok, Dong Liu, C. Bildstein, 2005, The Journal of Membrane Biology.

Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial

J. D. de Fijter, A. Hartmann, B. Tönshoff, 2008, Transplantation.

Evaluation of the effect of food and gastric pH on the single‐dose pharmacokinetics of cabozantinib in healthy adult subjects

J. Grenier, L. Nguyen, S. Lacy, 2015, Journal of clinical pharmacology.

One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation.

G. Verleden, R. Speich, P. Corris, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Delayed Introduction of Reduced‐Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT' Study

J. Neuberger, D. Samuel, P. Neuhaus, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Three-Year Allograft Vasculopathy Results of the Multicenter Heart Transplant Mycophenolate Mofetil Randomized Trial

D. Renlund, H. Valantine, L. Miller, 1999 .

Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.

E. Anaissie, J. Wingard, S. Kusne, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatic Disease and Drug Pharmacokinetics

R. Williams, Roger L. Williams, R. Mamelok, 1980, Clinical pharmacokinetics.

UGT1A9 −275T>A/−2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus‐Treated Kidney Transplant Patients

A. Hartmann, K. Budde, R. Schaik, 2009, Clinical pharmacology and therapeutics.

Treatment of Invasive Fungal Infections in Renally Impaired Patients with Amphotericin B Colloidal Dispersion

E. Anaissie, G. Noskin, Carole B. Miller, 1998, Antimicrobial Agents and Chemotherapy.

Study Design/Process of Development: Clinical Studies

R. Mamelok, 2012 .

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.

F. Oppenheimer, D. Kuypers, D. Hernández, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Toxic reaction to methotrexate in a patient receiving penicillin and furosemide: a possible interaction.

D. Nierenberg, R. Mamelok, 1983, Archives of dermatology.

Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.

T. Blaschke, R. Mamelok, D. Garfinkel, 1987, Annals of internal medicine.

Kinetics of D-glucose transport into renal membrane vesicles: measurements using a vacuum manifold apparatus.

S. Prusiner, J. Hoefer, R. Mamelok, 1981, Journal of biochemical and biophysical methods.

AcylMPAG Plasma Concentrations and Mycophenolic Acid-Related Side Effects in Patients Undergoing Renal Transplantation Are Not Related to the UGT2B7-840G>A Gene Polymorphism

A. Hartmann, V. Armstrong, K. Budde, 2008, Therapeutic drug monitoring.

Renal Sparing by Amphotericin B Colloidal Dispersion: Clinical Experience in 572 Patients

M. Gurwith, R. Mamelok, C. Du Mond, 1999, Chemotherapy.

Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard‐dose or reduced‐dose tacrolimus in liver transplant recipients

P. Neuhaus, F. Durand, J. Klempnauer, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant Recipients

B. Nashan, D. Kuypers, F. Vincenti, 2009, Clinical pharmacokinetics.

The Challenge of Achieving Target Drug Concentrations in Clinical Trials: Experience From the Symphony Study

H. Tedesco-Silva, F. Vincenti, T. Pearson, 2009, Transplantation.

Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants

M. Newman, P. Working, R. Bowden, 1995, Antimicrobial agents and chemotherapy.

The Population Pharmacokinetics of Amphotericin B Colloidal Dispersion in Patients Receiving Bone Marrow Transplants

M. Newman, P. Working, R. Bowden, 1999, Chemotherapy.

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

O. Frankfurt, S. Kambhampati, H. Kantarjian, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized double‐blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients

G. Klintmalm, R. Wiesner, J. Rabkin, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

M A Fischl, M. Fischl, D. Northfelt, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Separation of membrane-bound gamma-glutamyl transpeptidase from brush border transport and enzyme activities.

S. Prusiner, D. Groth, R. Mamelok, 1980, Biochemistry.

Mycophenolate Sodium Does Not Reduce the Incidence of GI Adverse Events Compared with Mycophenolate Mofetil

N. Davies, B. Maes, H. Meier‐Kriesche, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Population pharmacokinetics and pharmacodynamics of pegylated‐liposomal doxorubicin in patients with AIDS‐related Kaposi's sarcoma

D. Northfelt, M. Amantea, R. Mamelok, 1997, Clinical pharmacology and therapeutics.

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.

J. V. Von Roenn, D. Northfelt, B. Dezube, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib

D. Ramies, R. Preston, T. Marbury, 2016, Journal of clinical pharmacology.

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

D. Renlund, H. Valantine, D. Mancini, 1998, Transplantation.

Alloxan stimulates p-aminohippurate uptake in renal basal-lateral membranous vesicles.

R. Mamelok, S. S. Tse, B. Edmonds, 1985, Biochimica et biophysica acta.

Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine

P. Rosenthal, S. Lobritto, M. Leung, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Binding and Degradation of Insulin by Isolated Renal Brush Border Membranes

R. Rabkin, R. Mamelok, J. Petersen, 1982, Diabetes.

Design and Conduct Considerations for First‐in‐Human Trials

M. Attar, Samuel O. Pine, B. Swift, 2018, Clinical and translational science.

Renal Transplant Patients at High Risk of Acute Rejection Benefit From Adequate Exposure to Mycophenolic Acid

J. D. de Fijter, K. Budde, L. Rostaing, 2010, Transplantation.

A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.

O. Frankfurt, F. Ravandi, J. Pagel, 2018 .

A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis

J. Drew, A. Nast, D. Pariser, 2019, American Journal of Clinical Dermatology.

Effects of divalent cations and sulfhydryl reagents on the p-aminohippurate (PAH) transporter of renal basal-lateral membranes.

R. Mamelok, C. Bildstein, S. S. Tse, 1983, The Journal of pharmacology and experimental therapeutics.